Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.

MLA

Beroukhim, Rameen, et al. “Assessing the Significance of Chromosomal Aberrations in Cancer: Methodology and Application to Glioma.” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 50, Dec. 2007, pp. 20007–12. EBSCOhost, https://doi.org/10.1073/pnas.0710052104.

APA

Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., Du, J., Kau, T., Thomas, R. K., Shah, K., Soto, H., Perner, S., Prensner, J., Debiasi, R. M., Demichelis, F., … Sellers, W. R. (2007). Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America, 104(50), 20007–20012. https://doi.org/10.1073/pnas.0710052104

Chicago

Beroukhim, Rameen, Gad Getz, Leia Nghiemphu, Jordi Barretina, Teli Hsueh, David Linhart, Igor Vivanco, et al. 2007. “Assessing the Significance of Chromosomal Aberrations in Cancer: Methodology and Application to Glioma.” Proceedings of the National Academy of Sciences of the United States of America 104 (50): 20007–12. doi:10.1073/pnas.0710052104.